197 related articles for article (PubMed ID: 33795269)
1. Spontaneous bilateral peri-orbital purpura: an important clinical sign of primary systemic amyloidosis.
Beatty PE; Killion L; Mc Hugh J; Tobin AM
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33795269
[TBL] [Abstract][Full Text] [Related]
2. [Periorbital purpura: a pathognomonic but late sign of AL amyloidosis].
Visconti L; Cernaro V; Ferrara D; Lacava V; Ricciardi CA; Di Mauro E; Amico L; Santoro D; Buemi M
G Ital Nefrol; 2015; 32(5):. PubMed ID: 26480258
[TBL] [Abstract][Full Text] [Related]
3. Light and heavy chain deposition disease with focal amyloid deposition diagnosed with mass spectrometry: a case report.
Shimamoto Y; Takahashi N; Katoh N; Matsui Y; Mochizuki Y; Ito M; Yazaki M; Kametani F; Kasuno K; Sekijima Y; Naiki H; Iwano M
BMC Nephrol; 2023 Jun; 24(1):187. PubMed ID: 37365566
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
[TBL] [Abstract][Full Text] [Related]
5. Systemic light-chain amyloidosis incidentally diagnosed after subtotal parathyroidectomy and thyroid lobectomy.
Tsai K; Yu AC; Livhits MJ; Sajed D; Leung AM; Cheung DS
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33875506
[TBL] [Abstract][Full Text] [Related]
6. Muscle involvement with pseudohypertrophy in systemic light chain amyloidosis: Case report.
Draghici M; Jercan A; Badelita SN; Irimia RM; Bastian AE; Dobrea C; Popescu M; Coriu D
Medicine (Baltimore); 2021 Dec; 100(51):e28267. PubMed ID: 34941106
[TBL] [Abstract][Full Text] [Related]
7. Macroglossia as the initial presentation of AL amyloidosis: review and updates in treatment.
Cherico AS; Rizvi A; Jayakrishnan T; Mewawalla P
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35817492
[TBL] [Abstract][Full Text] [Related]
8. [Purpura: primary systemic amyloidosis manifestation].
Lestre S; Gonçalves A; João A; Ferreira A; Apetato M
Acta Med Port; 2009; 22(3):307-12. PubMed ID: 19686633
[TBL] [Abstract][Full Text] [Related]
9. Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.
Siragusa S; Morice W; Gertz MA; Kyle RA; Greipp PR; Lust JA; Witzig TE; Lacy MQ; Zeldenrust SR; Rajkumar SV; Russell SJ; Hayman SR; Buadi F; Kumar SK; Dingli D; Dispenzieri A
Ann Hematol; 2011 Jan; 90(1):101-6. PubMed ID: 20645101
[TBL] [Abstract][Full Text] [Related]
10. Classic features of primary systemic amyloidosis (AL amyloidosis) leading to diagnosis of plasma cell myeloma.
Tan KW; Zhu B; Behrens E; Tarbox MB
Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738847
[TBL] [Abstract][Full Text] [Related]
11. Primary systemic amyloidosis associated with multiple myeloma.
Oliveira EV; Pozetti AC; Pozetti EM; Antonio JR; Michalany NS
An Bras Dermatol; 2012; 87(1):119-22. PubMed ID: 22481660
[TBL] [Abstract][Full Text] [Related]
12. An interesting case of AL amyloidosis and MM: a complex scenario with cardiac involvement.
Gaba M; Kumar N; Pandey A; Dewan A
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38272507
[TBL] [Abstract][Full Text] [Related]
13. Diffuse parenchymal pulmonary amyloidosis associated with multiple myeloma: a case report and systematic review of the literature.
Liu Y; Jin Z; Zhang H; Zhang Y; Shi M; Meng F; Sun Q; Cai H
BMC Cancer; 2018 Aug; 18(1):802. PubMed ID: 30089469
[TBL] [Abstract][Full Text] [Related]
14. Macroglossia Associated With Primary Systemic Amyloidosis - Case Report With Unusual Clinical Presentation.
Muniyan S; Nair Sreela LS; Mathew P; Prasad T; Nair AS; Jose M
J Ayub Med Coll Abbottabad; 2022; 34(1):197-199. PubMed ID: 35466653
[TBL] [Abstract][Full Text] [Related]
15. Macroglossia, the first manifestation of systemic amyloidosis associated with multiple myeloma: Case report.
Maturana-Ramírez A; Ortega AV; Labbé FC; de Moraes Ê; Aitken-Saavedra JP
J Stomatol Oral Maxillofac Surg; 2018 Dec; 119(6):514-517. PubMed ID: 29953958
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2024 Feb; 99(2):309-324. PubMed ID: 38095141
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2022 Jun; 97(6):818-829. PubMed ID: 35429180
[TBL] [Abstract][Full Text] [Related]
18. Multiple myeloma with hepatic amyloid light-chain amyloidosis manifesting as progressive liver failure.
Oye M; Sanders K; Ghali M; Alkhasawneh A
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32601138
[TBL] [Abstract][Full Text] [Related]
19. AL-Kappa Primary Amyloidosis with Apolipoprotein A-IV Deposition.
Ishimitsu A; Tojo A; Hirao J; Yokoyama S; Ohira T; Murayama Y; Ishimitsu T; Kang D; Honda K; Ehara T; Ishida K; Ueda Y
Intern Med; 2022; 61(6):871-876. PubMed ID: 35296622
[TBL] [Abstract][Full Text] [Related]
20. Extensive haemorrhagic-bullous skin manifestation of systemic AA-amyloidosis associated with IgGlambda-myeloma.
Grundmann JU; Bonnekoh B; Gollnick H
Eur J Dermatol; 2000 Mar; 10(2):139-42. PubMed ID: 10694315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
